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Summary 
 
Background. The i-gel differs from other supraglottic airway devices in that it has a softer 
and a non-inflatable cuff. This study was designed to compare the performance of the i-gel 
and the LMA Unique when used during anaesthesia in paralysed patients. 
 
Methods. The devices were studied in 39 anaesthetised, paralysed patients by randomized 
crossover trial. The primary outcome was airway leak pressure. Secondary outcomes 
included the time for insertion, the number of insertion and reposition attempts, leak volumes 
and leak fractions. 
 
Results. There was no significant difference between the airway leak pressures of the two 
devices (median [IQR] values, i-gel 25 [22-30] cm H2O and LMA Unique 22 [20-28] cm 
H2O; p = 0.083). The median [IQR] insertion time for the i-gel (12.2 [9.7-14.3] s) was 
significantly less than for the LMA Unique (15.2 [13.2-17.3] s; p = 0.007). All the LMA 
Uniques and 38/39 i-gels were inserted at the first attempt. The number of manipulations 
required after insertion to achieve a clear airway was same in both the groups (four in each). 
There were no statistically significant differences in the leak volumes or leak fractions during 
controlled ventilation.  
 
Conclusions. We were unable to demonstrate any difference in efficacy of seal and success 
rate of first-time insertion between the i-gel and the LMA Unique although the insertion 
times for the i-gel are significantly shorter when compared to the LMA Unique. We conclude 
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that the i-gel provides a reasonable alternative to the LMA-U for controlled ventilation during 
anaesthesia. 
Keywords: equipment, airway; equipment, masks, laryngeal; ventilation, mechanical 
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The i-gel (Intersurgical Ltd, Wokingham, UK) is a relatively new, single use supraglottic 
airway device (SAD) designed for use during anaesthesia.1 Unlike the conventional LMAs it 
does not have an inflatable cuff. The i-gel is made from a soft, gel-like, and transparent 
medical grade thermoplastic elastomer (Styrene Ethylene Butadiene Styrene). The cuff has 
been designed to create a non-inflatable anatomical seal by a shape which is a mirror 
impression of the supraglottic anatomy. A studies performed on manikins showed that the 
insertion of the i-gel was significantly easier when compared with insertion of other SADs.2  
There is evidence to suggest that it is easier to train non-anaesthetists how to correctly insert 
i-gels, compared with the conventional SADs, thus making it a potentially useful device for 
situations such as resuscitation.3-5 Recent studies show that the i-gel provides a good seal 
during anaesthesia for spontaneously breathing patients as well as for controlled ventilation.6–
8 We are unaware of any published studies performed on live humans which have compared 
its performance with other well established SADs for controlled ventilation. LMA Unique 
(LMA-U; Intavent Orthofix, UK) is the single-use form of the LMA classic.  This study was 
designed to compare the adequacy of seal and ease of insertion of the i-gel and the LMA-U 
during anaesthesia in paralysed patients. 
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Methods 
 
After obtaining approval from the Local Research Ethics Committee and written informed 
consent, we recruited 40 adult patients to a prospective randomised crossover clinical trial. 
Patients undergoing elective surgery that involved tracheal intubation were recruited to the 
study. Patients, ASA I–II, age 16–70 yr, who had the ability to give informed consent, were 
included in the study. The exclusion criteria were presence of any significant acute or chronic 
lung disease, pathology of the neck or upper respiratory tract, potential difficult intubation, an 
increased risk of aspiration (hiatus hernia, gastro-oesophageal reflux, or full stomach), 
pregnant women, BMI>35 kg.m-2 and patients unable to communicate in English.  
 
We used the Datex-Ohmeda Aestiva/5 anaesthetic machine (GE Healthcare) with its built-in 
pressure gauge and spirometer attachment for the study. Before induction of anaesthesia, the 
anaesthetic machine and circuits were checked as per manufacturer’s guidelines. Intravenous 
access was secured and standard monitoring, including a peripheral nerve stimulator, was 
attached. After preoxygenation, anaesthesia was induced with fentanyl 1 microgram.kg-1 and 
a target control infusion (TCI) of propofol to achieve a target plasma concentration of 
propofol to 4–7 microgram.ml-1. On loss of verbal contact, the anaesthetist checked that the 
patient could be hand-ventilated with a facemask. A bolus dose of rocuronium 0.5 mg.kg-1 
was then given. Neuromuscular blockade was confirmed using a train-of-four stimulation 
count (TOF = 0).  
 
The patients were randomly allocated to one of the two groups using sequentially numbered 
sealed opaque envelopes naming the airway device to be evaluated first. The insertions were 
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performed by a single user (SG) who had an experience of more than 1000 insertions of any 
type of SAD including more than 90 i-gel insertions and more than 200 LMA-U insertions. 
The i-gel was inserted in accordance with manufacturer’s guidelines. Size selection of the i-
gel depended on patient weight: size 3 was used for patients <50 kg, size 4 was used for those 
between 50 and 90 kg, and size 5 was used for those over 90 kg in weight. Similarly for the 
LMA-U we followed a weight based algorithm recommended by the manufacturers: size 3 
was used for patients <50 kg, size 4 was used for those between 50 and 70 kg, and size 5 was 
used for those over 70 kg. The cuff of the LMA-U was inflated to two-thirds of the maximum 
recommended volume as this usually provides most effective seal.9  Therefore size 3, 4 and 5 
LMA-U were inflated with 13, 20 and 26 ml of air respectively. We did not measure cuff 
pressures using an aneroid cuff pressure gauge as this does not reflect our usual clinical 
practice.    
 
The time taken to insert the SAD was noted, this was defined as the time from picking up the 
SAD to first breath made by manual ventilation. Adequate placement of the SAD was 
assessed by gently squeezing the reservoir bag and observing the end-tidal carbon dioxide 
waveform and chest movements. If ventilation was inadequate, the following manipulations 
were allowed: gentle pushing or pulling of the device, chin lift, jaw thrust, head extension, or 
neck flexion. The number of attempts required for insertion was recorded. A ‘failed attempt’ 
was defined as removal of the device from the mouth before re-insertion. Two attempts were 
allowed before device use was considered a failure. In the event of adequate ventilation not 
achieved using either SAD, the protocol was that the trachea of participant would be 
intubated using a standard tracheal tube and the participant would be excluded from the 
study. The number of manipulations and abandonment of the device after insertion and 
during maintenance of anaesthesia were recorded. TCI propofol with oxygen-enriched air 
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was used for maintenance of anaesthesia during data collection. Once a clear airway was 
established, the lungs were ventilated at three different pressures (15, 20, 25 cm H2O) using 
pressure-controlled ventilation (PCV) at a rate of 10 bpm and an inspiratory-to-expiratory 
ratio of 1:2 with no positive end expiratory pressure. Inspired and expired tidal volumes were 
recorded. Measurements were taken over 10 breaths for each pressure setting. Gastric 
insufflation was assessed by auscultation over the patient’s epigastric area. Airway leak tests 
were then performed. The fresh gas flow was adjusted to 3 litre.min-1 and the adjustable 
pressure limiting (APL) valve of the circle system was completely closed. Airway pressures 
were not allowed to exceed 40 cm H2O. 
• Test 1 (auscultation) measuring the minimal airway pressure at which an audible gas 
leak occurred using a stethoscope placed just lateral to thyroid cartilage. 
• Test 2 (manometer stability) involving observation of the aneroid manometer dial as 
the pressure from the breathing system increased and noting the airway pressure at 
which the dial reached stability (i.e. the airway pressure at which the leak was in 
equilibrium with fresh gas flow). 
Following completion of the above tests the first SAD was removed and any visible blood on 
the SAD was noted. The second SAD was then inserted after rechecking neuromuscular 
blockade and the previous measurements were repeated. 
 
The difference between inspired tidal volume (ITV) and expired tidal volume (ETV) was 
used to calculate leak volume (LV), i.e. LV=ITV – ETV. The leak fraction was defined as 
leak volume divided by ITV (i.e. leak fraction=LV/ITV).  
 
The primary outcome for the study was the airway leak pressure of the two SADs. For 
sample size calculation, we consider a 5 cm H2O to be a clinically significant difference.10 A 
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previous study with the LMA-U showed the average airway leak pressure to be 19 cm H2O 
with a standard deviation of 5 cm H2O.11 A two sample study design, using a t-test for 
comparison of group means, would therefore require a total of 34 patients for 80% power at a 
significance level of 5% (nQuery Advisor® 4.0). Our study used a crossover design and 
should have greater power to detect discernable differences between the devices. However, 
there was no data available on the within-subject variability of the primary endpoint, so it was 
unclear whether within-patient differences would follow a normal distribution, as would be 
assumed in a paired t-test. We therefore decided to recruit 40 patients to allow for the 
imprecision in the power calculation and to allow for some loss of patients from the study. 
Patients were randomised to one of the two possible orderings of the devices in equal 
proportion, in random permuted blocks of 4 and 6.  
Airway leak pressures, insertion times, leak volumes and leak fractions were not normally 
distributed. However the differences between airway leak pressures of the two SADs were 
normally distributed (Kolmogorov-Smirnov test). Therefore the former were analysed using 
the Wilcoxon sign-rank test and the later was analysed using a paired t-test. Fisher’s exact 
test was used to assess whether the first time success rates, number of manipulations and 
trauma rates were different between the two devices. Statistical analysis was performed using 
MINITAB 15.1 Statistical Software (Minitab Inc., State College, USA). 
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Results.  
 
Forty patients were recruited to the study; one patient was excluded from analysis because of 
calibration error of spirometer. The mean (SD) age, weight, and BMI of the participants are 
shown in Table 1. Majority of participants underwent gynaecological surgery (22/39), 
followed by general surgery (15/39) and orthopaedic surgery (2/39). The results of the study 
are summarised in Table 2 
 
The mean [SD] difference in the airway leak pressure between the two devices was 2.8 [8.0] 
cm H2O in favour of the i-gel (95% CI -0.32, 4.88 cm H2O; p=0.084). The median [IQR] 
difference in the insertion time between the two devices was 2.3 [0.2-4.4] seconds again in 
favour of the i-gel (95% CI 1.05, 3.40 s; p=0.007). The difference between leak volumes and 
leak fractions was not significant between the groups. There were 3 cases of difficult 
insertion in the i-gel group and one difficult insertion in the LMA-U group. On analysis using 
Fisher’s exact test the incidence of difficult insertions between the groups was statistically 
not different (p = 0.358). Number of manipulations required to achieve a clear airway was 
same in both the groups (four in each group). An acceptable airway could be achieved for all 
the study patients with both the SADs. Airway leak pressure above 40 cm H2O was achieved 
for three patients in each group. None of the participants in our study tested positive for 
gastric insufflations by auscultation over epigastric area using either of SADs. There were no 
adverse events such as regurgitation or aspiration during the study.   
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Discussion 
 
Since its introduction to the UK market in January 2007, the i-gel has been widely used as a 
SAD during anaesthesia and cardiopulmonary resuscitation. Apart from a soft, non-inflatable 
cuff, which may make its insertion easy and less traumatic, it has several design features 
which make it a useful SAD. It has a gastric channel which may allow early recognition of 
regurgitation of gastric contents and passage of a drainage tube. It has an epiglottic ridge 
which is designed to rest on the base of tongue and may prevent upward and outward 
movement. It has a ridged flattened stem to aid insertion and may reduce risk of axial 
rotation. Most of these designed features have not been tested in humans. An observational 
study evaluating its performance found the i-gel as a promising SAD.6 However, we were 
unable to identify any published trials comparing the performance of the i-gel with its likely 
competitors for use during controlled ventilation. LMA-U is a commonly used single use 
SAD which has been shown to have similar clinical performance to the reusable LMA 
classic.12   
 
Comparing the two SADs we found that the median insertion time for the i-gel (12.2 s) was 
significantly shorter than the LMA-U (15.2s). This difference although statistically 
significant may not be clinically important but is an indication of ease of insertion. It is quite 
likely that this time difference might be a reflection of the time need for the cuff inflation of 
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the LMA-U. Bamgbade et al in an evaluation study of 300 i-gel insertions reported that in 
290 patients the i-gel could be inserted within 5 s, but they did not specify how they defined 
insertion time.13 This is very different to others studies which show median insertion time for 
the i-gel and the LMA-U as 15 s and 24 s respectively.6, 11 Shorter insertion times in both the 
groups in our study may be related to the experience of the user. High first time insertion rate, 
low failure rate and low incidence of mucosal trauma in our study may be because of the 
same reason. A recent study showed that the experience had no effect on insertion but that 
study was done on manikins and the conclusion may not apply to live subjects.5  
There was no statistical difference between the median airway leak pressure achieved with 
the i-gel (25 cm H2O) and the LMA-U (22 cm H2O). The values of airway leak pressure 
found in our study are similar to those in previous studies. The median airway leak pressure 
for the i-gel has been quoted as 24-28 cm H2O,6,8 whereas the values for the LMA-U have 
been shown to be 18-25 cm H2O.14-15 No significant differences in the airway leak pressures, 
leak volumes and leak fractions suggest that the efficacy of seal provided by both devices is 
equivalent. 
There was no evidence of gastric insufflation, regurgitation, or aspiration while using any of 
the SAD during our study. The incidence of regurgitation and aspiration with the use of the i-
gel is not known. Three cases of regurgitation of which one of them had a confirmed 
aspiration have been reported.16 In all these cases the gastric channel allowed early 
identification of the regurgitation. The incidence of clinically detectable gastric insufflations 
and regurgitation with the use of LMAs in general is 0-0.3% and 0.07% respectively.17 The 
incidence of aspiration with LMAs in fasted patients is 0.012%.17   
As in our previous study, we used pressure-controlled mode instead of volume-controlled 
mode for controlled ventilation.8 This is because the amount of leak volume is affected by the 
pressure generated between the airway device and the supraglottic tissues. Furthermore there 
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is evidence to suggest that PCV is more efficient and safer than volume-controlled ventilation 
for controlled ventilation with a SAD.18 Similarly we did not assess the anatomical position of 
the device in relation to vocal cords with fibreoptic bronchoscope as it has been shown that 
there is no correlation between fibreoptic scores and airway leak pressures.19-20 
 
Our study has several limitations. Firstly, the data was collected by an unblinded observer so 
we cannot exclude an element of bias, although by the use of a crossover design we were able 
to limit the influence of interpatient variability during the comparison. Secondly, both the 
devices were inserted by a single experienced user and our results may not be applicable to 
inexperienced users. Finally, because of the crossover design, we were unable to determine 
which SAD has higher airway morbidity. This needs a larger non-crossover or an 
observational study. 
 
In summary, we were unable to demonstrate any difference in efficacy of seal and success 
rate of first-time insertion between the i-gel and the LMA-U.  The insertion time for the i-gel 
was marginally shorter. We conclude that the i-gel provides a reasonable alternative to the 
LMA-U for controlled ventilation during anaesthesia. 
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Table 1 Patient characteristics. Values given as mean (SD) or absolute numbers 
Parameters n = 39 
Sex; Males: Females 
Age; (years) 
Weight; (Kg) 
Body Mass Index; kg m-2 
2:37 
47.8 (12.2) 
70.3 (11.9) 
26.3 (4.1) 
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Table 2 Values are expressed as median (IQR) or actual number (n=39). * p = 0.007 
 i-gel  LMA Unique 
Ease of insertion 
Insertion times; s 
Insertion attempts; First/ Second 
Failed insertions 
 
Efficacy of seal 
Airway leak pressure; cm H2O 
(Manometer method) 
Airway leak pressure; cm H2O 
(Auscultation method) 
 
Leak Volume; ml 
15 cm H2O PCV 
20 cm H2O PCV 
25 cm H2O PCV 
Leak Fraction 
15 cm H2O PCV 
20 cm H2O PCV 
25 cm H2O PCV 
 
Mucosal trauma 
Visible blood (first device) 
 
 
12.2 (9.7-14.3) 
38/ 1 
0 
 
 
25.0 (22.0-30.0) 
 
25.0 (22.0-30.0) 
 
 
 
30 (20.0-61.0) 
34 (21.0-126.0) 
43 (23.0-178.0) 
 
0.07 (0.03-0.15) 
0.04 (0.03-0.13) 
0.04 (0.02-0.16) 
 
 
1 
 
 
15.2 (13.2-17.3)* 
39/ 0 
0 
 
 
22.0 (20.0-28.0) 
 
22.0 (20.0-28.0) 
 
 
 
21 (13.0-36.0) 
28 (20.0-50.0) 
48 (23.0-165.0) 
 
0.04 (0.02-0.09) 
0.04 (0.02-0.08) 
0.05 (0.02-0.17) 
 
 
0 
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